Article
Woke Star Trek Series Canceled After Embarrassing Critical Failure
Woke Star Trek Series Canceled After Embarrassing Critical Failure
"Get Woke, Go Broke" wins once again.
For many years the political left in Hollywood along with the allied progressive media argued that wokeness was the dominant social trend of our era. They claimed that any company that refused to adapt to the new far-left "modern audience" would be choking on the dust of companies that wrapped themselves in the rainbow flag. They asserted that the entertainment industry had to change and reflect this new ideological movement if they wanted to remain...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Aug 13, 2026 / Tyler Durden
"No Rock Left Unturned": Tether Completes Independent Audit Of Reserves With KPMG
Jun 29, 2026 / Tyler Durden
Alaska Judge Overrules Election Officials, Lets 'Fake' Dan Sullivan Stay On Ballot
Alaska Judge Overrules Election Officials, Lets 'Fake' Dan Sullivan Stay On Ballot
A retired elementary school teacher from Petersburg just punched his ticket back onto Alaska's Republican U.S. Senate primary ballot after he was accused of being a deliberate spoiler and struck from the ballot.
Dan Sullivan of Petersburg announced his campaign for the U.S. Senate on May 29 to challenge incumbent U.S. Sen. Dan Sullivan. (Photo courtesy of Dan Sullivan)
Superior Court Judge Thomas Matthews ruled late Friday that the Alaska Division of Elections had no legal right to disqualify Daniel...
Read more
May 21, 2026 / Tyler Durden
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery.
In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks:
12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight.
9 mg dose: average weight loss of 64.4 pounds, or 25.9%.
4 mg dose: average weight loss of 47.2 pounds, or 19%
Ahead of the results,...
Read more




